News

By Lori Solomon HealthDay ReporterTUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
A new King’s College London study links abdominal fat—not general obesity—to increased psoriasis risk, especially in women, ...
BELLY fat increases your risk of the skin condition psoriasis, a study warns. Psoriasis, which affects one in 50 people – ...
People with scalp psoriasis may experience itchy ... The condition will also not result in thick plaques as psoriasis would. Seborrheic dermatitis is a common condition that causes itchy, flaky ...
STOCKHOLM, Sweden, 24th May 2025 - (Nasdaq First North: LIPI) reports negative results from a Phase III clinical study of the AKP02G2 cutaneous spray for mild to moderate plaque psoriasis. The study, ...
Many Americans unknowingly misidentify various skin conditions, attributing every bump, patch or discoloration to ordinary ...